💉 GLP-1/GIP Weight Loss Drug Mechanism

SELECT Trial 3D Cohort Map — Semaglutide CV Outcome SimulatorNew📱3D companion to the SELECT trial simulator: two patient-cohort lattices float on separate… Semaglutide Appetite Suppression Mechanism SimulatorNewA mechanism by which semaglutide (Ozempic/Wegovy) suppresses appetite through GLP-1… Tirzepatide Dual GIP/GLP-1 Agonist SimulatorNewThe dual action of tirzepatide (Mounjaro/Zepbound) on GIP and GLP-1 receptors. GLP-1 Gastric Emptying Delay Satiety SimulatorNewA delay in gastric emptying and satiety sensation under GLP-1 therapy. Weight Loss Drug Dose Titration Schedule SimulatorNewA schedule for the gradual titration of a weight loss drug dose. GLP-1 Muscle Mass Preservation Strategy SimulatorNewThis simulation explores the strategy of preserving muscle mass during GLP-1 therapy. It… Semaglutide Cardiovascular Outcome Trial SimulatorNewThis simulation focuses on the cardiovascular outcomes of semaglutide as demonstrated in the… Compounded Semaglutide Safety Risk SimulatorNewThis simulation examines the safety risks associated with compounded semaglutide outside of… GLP-1 Drug Shortage Access Equity SimulatorNewThis simulation addresses the issue of access to GLP-1 drugs when there is a shortage. It…